Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Chris Wack LIXTE Biotechnology shares were up 14% to $2.27 after the company said it has dosed the first patient in a Phase 1b/2 clinical trial to assess...
By Adam L. Cataldo Shares of Corbus Pharmaceuticals Holdings more than tripled on Friday after it reported positive results from its first-in-human study of...
By Rob Curran Vera Therapeutics rose after the biotech firm said one of its product candidates showed promise in a mid-stage trial on patients with a kidney...
By Helena Smolak Ipsen's phase-three trial of prostate cancer drug Cabometyx yielded positive results, the company said late Monday. The French...
By Denny Jacob Scholar Rock Holding said the Food and Drug Administration cleared its investigational new drug application for its Phase 2 trial of...